NCT04671381 Improving Access and Affordability of Adult Hearing Healthcare
| NCT ID | NCT04671381 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Alabama, Tuscaloosa |
| Condition | Hearing Loss |
| Study Type | INTERVENTIONAL |
| Enrollment | 210 participants |
| Start Date | 2021-01-01 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 210 participants in total. It began in 2021-01-01 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project will address quality of care issues associated with hearing loss in adults who have mild-to-moderate hearing loss and who have no access to hearing healthcare. Through the use of three different interventions involving over-the-counter hearing aids, it will lead to options that will increase access and affordability of hearing healthcare for adults with mild-to-moderate hearing loss.
Eligibility Criteria
Inclusion Criteria: * Mild-to-moderate hearing loss * Live in West Central or South Alabama * 40 years of age or older Exclusion Criteria: • Medical conditions resulting in severe cognitive impairment (e.g., stroke, head injury, senile dementia or Alzheimer's disease)
Contact & Investigator
Marcia J Hay-McCutcheon, PhD
PRINCIPAL INVESTIGATOR
The University of Alabama, Tuscaloosa
Frequently Asked Questions
Who can join the NCT04671381 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, studying Hearing Loss. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04671381 currently recruiting?
Yes, NCT04671381 is actively recruiting participants. Contact the research team at mhaymccu@ua.edu for enrollment information.
Where is the NCT04671381 trial being conducted?
This trial is being conducted at Tuscaloosa, United States.
Who is sponsoring the NCT04671381 clinical trial?
NCT04671381 is sponsored by University of Alabama, Tuscaloosa. The principal investigator is Marcia J Hay-McCutcheon, PhD at The University of Alabama, Tuscaloosa. The trial plans to enroll 210 participants.